➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
Moodys
Mallinckrodt
Harvard Business School

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

DOBUTAMINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Dobutamine Hydrochloride, and what generic alternatives are available?

Dobutamine Hydrochloride is a drug marketed by Baxter Hlthcare, Dr Reddys, Hospira, Luitpold, Teligent, Teva Parenteral, Watson Labs, Watson Labs Inc, and West-ward Pharms Int. and is included in fourteen NDAs.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dobutamine Hydrochloride

A generic version of DOBUTAMINE HYDROCHLORIDE was approved as dobutamine hydrochloride by HOSPIRA on November 29th, 1993.

  Try it Free

Summary for DOBUTAMINE HYDROCHLORIDE
Drug patent expirations by year for DOBUTAMINE HYDROCHLORIDE
Recent Clinical Trials for DOBUTAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institute of Liver and Biliary Sciences, IndiaN/A
Assistance Publique - HĂ´pitaux de ParisPhase 3
Centre d’Investigation Clinique 1415Phase 3

See all DOBUTAMINE HYDROCHLORIDE clinical trials

Pharmacology for DOBUTAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DOBUTAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DOBUTAMINE HYDROCHLORIDE

US Patents and Regulatory Information for DOBUTAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074381-001 Sep 26, 1996 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Baxter Hlthcare DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dobutamine hydrochloride INJECTABLE;INJECTION 020255-005 Oct 19, 1993 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teligent DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074098-001 Feb 21, 1995 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hospira DOBUTAMINE HYDROCHLORIDE dobutamine hydrochloride INJECTABLE;INJECTION 074086-001 Nov 29, 1993 AP RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hospira DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% dobutamine hydrochloride INJECTABLE;INJECTION 020269-001 Oct 19, 1993 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
Moodys
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.